Cytek Biosciences Inc (CTKB) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Cytek Biosciences Inc   (NASDAQ: CTKB)

Cytek Biosciences Inc Profitability Comparisons

Select each Category to receive further Information




CTKB Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 58.87 % 51.85 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) 53.65 % 51.54 % 55.83 % 38.1 %
Gross Profit Margin 5 Yr. Avg. 57.53 % 50.01 % 52.78 % 32.58 %
EBITDA Margin (Q2 MRQ) 4.93 % 10.73 % 21.71 % 22.17 %
EBITDA Margin (Q2 TTM) -0.74 % 12.49 % 23.59 % 20.86 %
EBITDA Margin 5 Yr. Avg. 0.44 % 11.41 % 34.71 % 23.59 %
Operating Margin (Q2 MRQ) -23.68 % 9.69 % 16.59 % 16.03 %
Operating Margin (Q2 TTM) -24.88 % 10.53 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. --7.74 % 9.71 % 14.73 % 16.68 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % -0.48 % 10.94 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -5.75 % 3.84 % 12.84 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 0.67 % 10.65 % 12.24 %
Net Margin (Q2 MRQ) -1.07 % 1.22 % 8.14 % 11.41 %
Net Margin (Q2 TTM) -28.32 % 7.64 % 9.96 % 10.76 %
Net Margin 5 Yr. Avg. - 4.84 % 6.13 % 9.62 %



Business Segment Profit Margin
 
United States
  Explore United States Segment  -
Product
  Explore Product Segment  -
Service
  Explore Service Segment  -
EMEA
  Explore EMEA Segment  -
APAC
  Explore APAC Segment  -
Other
  Explore Other Segment  -
Reportable
  Explore Reportable Segment  -
Asia Pacific
  Explore Asia Pacific Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) -1.82 % 1.89 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) -6.74 % 11.61 % 14.06 % 9.36 %
Free Cash Flow Margin 5 Yr. Avg. - 12.19 % 15.77 % 13.94 %
Net Cash Flow Margin (Q2 MRQ) 0 % -0.34 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) -14.45 % 0.35 % 0.09 % 1.8 %
Net Cash Flow Margin 5 Yr. Avg. - -0.02 % 3.09 % 5.71 %
Effective Tax Rate (Q2 MRQ)